Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects. 1978

P Micossi, and A E Pontiroli, and S H Baron, and R C Tamayo, and F Lengel, and M Bevilacqua, and U Raggi, and G Norbiato, and P P Foà

Normal subjects and patients with adult-onset diabetes received 10 gm. of aspirin in four days. On the fourth day, the fasting serum glucose and the glucose response to oral glucose were decreased in both groups. These changes were associated with increased levels of serum insulin and pancreatic glucagon, although the glucagon responses to oral glucose were unchanged. In the diabetic patients, aspirin therapy was followed by a decreased glucose response to I.V. glucose and by the appearance of an early insulin peak, which could not be demonstrated before treatment. Aspirin did not affect the I.V. glucose tolerance in normal subjects, although it did enhance the early insulin peak. A decrease in the fasting levels of free fatty acids was noted in both groups, whereas the fasting level of triglycerides decreased only in the diabetic patients. Cholesterolemia did not change in either group. A few preliminary observations indicate that, in normal subjects, ibuprofen and ketoprofen, two other presumed prostaglandin inhibitors, did not affect fasting glycemia, glucose tolerance, or the insulin response to glucose. No changes were noted after the administration of placebo.

UI MeSH Term Description Entries
D007052 Ibuprofen A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties Advil,Benzeneacetic Acid, alpha-methyl-4-(2-methylpropyl)- trimethylsilyl ester,Brufen,Ibumetin,Ibuprofen, (+-)-Isomer,Ibuprofen, (R)-Isomer,Ibuprofen, (S)-Isomer,Ibuprofen, Aluminum Salt,Ibuprofen, Calcium Salt,Ibuprofen, Copper (2+) Salt,Ibuprofen, Magnesium Salt,Ibuprofen, Potassium Salt,Ibuprofen, Sodium Salt,Ibuprofen, Zinc Salt,Ibuprofen-Zinc,Motrin,Nuprin,Rufen,Salprofen,Trauma-Dolgit Gel,alpha-Methyl-4-(2-methylpropyl)benzeneacetic Acid,Ibuprofen Zinc,Trauma Dolgit Gel
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007660 Ketoprofen An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis. Benzoylhydratropic Acid,19,583 RP,2-(3-Benzoylphenyl)propionic Acid,Alrheumat,Alrheumum,Orudis,Profenid,RP-19583,RP 19583,RP, 19,583,RP19583
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Micossi, and A E Pontiroli, and S H Baron, and R C Tamayo, and F Lengel, and M Bevilacqua, and U Raggi, and G Norbiato, and P P Foà
June 1975, The Tohoku journal of experimental medicine,
P Micossi, and A E Pontiroli, and S H Baron, and R C Tamayo, and F Lengel, and M Bevilacqua, and U Raggi, and G Norbiato, and P P Foà
May 1975, Metabolism: clinical and experimental,
P Micossi, and A E Pontiroli, and S H Baron, and R C Tamayo, and F Lengel, and M Bevilacqua, and U Raggi, and G Norbiato, and P P Foà
January 1995, Digestion,
P Micossi, and A E Pontiroli, and S H Baron, and R C Tamayo, and F Lengel, and M Bevilacqua, and U Raggi, and G Norbiato, and P P Foà
June 1969, The American journal of the medical sciences,
P Micossi, and A E Pontiroli, and S H Baron, and R C Tamayo, and F Lengel, and M Bevilacqua, and U Raggi, and G Norbiato, and P P Foà
October 1975, Diabetes,
P Micossi, and A E Pontiroli, and S H Baron, and R C Tamayo, and F Lengel, and M Bevilacqua, and U Raggi, and G Norbiato, and P P Foà
August 1990, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
P Micossi, and A E Pontiroli, and S H Baron, and R C Tamayo, and F Lengel, and M Bevilacqua, and U Raggi, and G Norbiato, and P P Foà
September 1995, The American journal of physiology,
P Micossi, and A E Pontiroli, and S H Baron, and R C Tamayo, and F Lengel, and M Bevilacqua, and U Raggi, and G Norbiato, and P P Foà
August 2014, Schizophrenia research,
P Micossi, and A E Pontiroli, and S H Baron, and R C Tamayo, and F Lengel, and M Bevilacqua, and U Raggi, and G Norbiato, and P P Foà
February 1998, Diabetes care,
P Micossi, and A E Pontiroli, and S H Baron, and R C Tamayo, and F Lengel, and M Bevilacqua, and U Raggi, and G Norbiato, and P P Foà
January 2017, BMJ open diabetes research & care,
Copied contents to your clipboard!